The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rodino-klapac Louise since 2021.
This trader's CIK number is 1836218.
At the time of last reporting, Rodino-klapac Louise was the Head of R&D, CSO of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SRPT | 0 | $0 | 0 | $0 | 23,000 | $0 |
| 2024 | SRPT | 0 | $0 | 0 | $0 | 6,250 | $0 |
| 2021 | SRPT | 3,780 | $299,867 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-07 | SRPT | Option Ex | 5,500 | .00 | 0 |
| 2025-03-06 | SRPT | Option Ex | 17,500 | .00 | 0 |
| 2024-06-21 | SRPT | Option Ex | 6,250 | .00 | 0 |
| 2021-11-24 | SRPT | Buy | 3,780 | 79.33 | 299,867 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rodino-klapac Louise (Head of R&D, CSO of Sarepta Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.